p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin.
Consistent with the excellent clinical results in testicular germ cell tumors (TGCT), most cell lines derived from this cancer show an exquisite sensitivity to Cisplatin. It is well accepted that the high susceptibility of TGCT cells to apoptosis plays a central role in this hypersensitive phenotype...
Main Authors: | Matthias Gutekunst, Moshe Oren, Andrea Weilbacher, Michael A Dengler, Christiane Markwardt, Jürgen Thomale, Walter E Aulitzky, Heiko van der Kuip |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3080918?pdf=render |
Similar Items
-
Dataset of testicular germ cell tumors (TGCT) risk associated with serum polychlorinated biphenyl (PCB) by age at diagnosis and histologic types
by: Zhiyuan Cheng, et al.
Published: (2021-06-01) -
Molecular Basis of Cisplatin Resistance in Testicular Germ Cell Tumors
by: Violeta Bakardjieva-Mihaylova, et al.
Published: (2019-09-01) -
Investigations of the molecular basis of cisplatin sensitivity in testicular germ cell tumours
by: Wang, Xianghong
Published: (1998) -
Repair shielding of platinum-DNA lesions in testicular germ cell tumors by high-mobility group box protein 4 imparts cisplatin hypersensitivity
by: Awuah, Samuel, et al.
Published: (2017) -
Efficacy of HDAC Inhibitors Belinostat and Panobinostat against Cisplatin-Sensitive and Cisplatin-Resistant Testicular Germ Cell Tumors
by: João Lobo, et al.
Published: (2020-10-01)